A study of patients with AD showed that egfr mRNA and EGFR protein levels are significantly higher in those at Braak stages V-VI (fully developed AD) than in those at Braak stages 0-II (clinically silent) (27). This evidence concerns the gene EGFR and Alzheimer disease.